Events Archives - MuReva Phototherapy

PRESS RELEASES

Mureva Announces FDA De Novo Authorization and Peer-Reviewed Publication of Pivotal Mureva OM Trial

Randomized, sham-controlled trial shows Mureva OM significantly reduced severe oral mucositis BRECKSVILLE, Ohio, September 10th, 2026— Mureva Phototherapy Inc. today…

Yesterday at 2:22 pm

Press Release

American Medical Association Establishes Category III CPT Code for Procedure Associated with the Use of MuReva Phototherapy’s LED-based Photobiomodulation Therapy Device

Obtaining this CPT code is an initial step to achieving reimbursement for the use of MuReva Phototherapy’s Photobiomodulation Therapy Device…

December 16, 2025

Press Release

MuReva Phototherapy Presents Data during 2025 ASTRO Meeting Confirming Safety and Efficacy of the Company’s LED-based Photobiomodulation Therapy Device

Study confirmed the safety and the ability of the company’s LED-based photobiomodulation therapy breakthrough device technology to reduce severity of…

October 28, 2025

PRESS RELEASES

Mureva Announces FDA De Novo Authorization and Peer-Reviewed Publication of Pivotal Mureva OM Trial

American Medical Association Establishes Category III CPT Code for Procedure Associated with the Use of MuReva Phototherapy’s LED-based Photobiomodulation Therapy Device

MuReva Phototherapy Presents Data during 2025 ASTRO Meeting Confirming Safety and Efficacy of the Company’s LED-based Photobiomodulation Therapy Device

Navigation

Socials

Contact